Qualigen Therapeutics Inc (NASDAQ:QLGN)
| 0.9325 Delayed Data As of May 26 |  +0.0096 / +1.04%Today’s Change | 0.83 Today|||52-Week Range 6.50 | -27.66% Year-to-Date |
Latest QLGN News | Press Releases
No recent news for Qualigen Therapeutics Inc.
Today’s Trading
| Previous close | 0.92 |
| Today’s open | 0.93 |
| Day’s range | 0.93 - 0.93 |
| Volume | 27 |
| Average volume (3 months) | 144,942 |
| Market cap | $4.9M |
Data as of 12:50pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | +20.44% |
| Earnings growth (this year) | +55.46% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -11.85% |
| P/E ratio | NM |
| Price/Sales | 0.99 |
| Price/Book | 0.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XBIOXenetic Biosciences ... | -0.36 | -10.43% |
| NBRVNabriva Therapeutics... | -0.04 | -2.19% |
| ---- | ||
| ADMPAdamis Pharmaceutica... | -0.34 | -13.60% |
Data as of 3:58pm ET, 05/26/2023
Financials
| Next reporting date | August 15, 2023 |
| EPS forecast (this quarter) | -$0.54 |
| Annual revenue (last year) | $5.0M |
| Annual profit (last year) | -$18.6M |
| Net profit margin | -374.04% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Carlsbad, California |
Forecasts
